{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-050333","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2026-07-29T10:13:52+00:00","discovered_at":"2026-07-29T10:15:00.320397+00:00","generated_at":"2026-07-29T10:15:04.869583+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Avantor Q2 net sales $1.69B, GAAP EPS $0.06, adj. EPS $0.21; raises FY guidance","bullets":["Net sales $1,692.3M, up 0.5% reported, organic -0.4%; net income $38.1M vs $64.7M prior year.","Adjusted EBITDA $254.3M (15.0% margin); adjusted EPS $0.21; operating cash flow $178.2M, free cash flow $142.8M.","VWR Distribution & Services organic +1.7%; Bioscience & Medtech Products organic -5.6%.","Updated FY 2026 guidance: organic revenue growth -0.5% to +0.5% (from -2.5% to -0.5%), adjusted EPS $0.80-$0.83.","Repaid $112.1M debt in Q2; total debt $3,715.4M, cash $306.8M; adjusted net leverage 3.3x."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-050333","json":"https://secwatch.observer/filing/0001628280-26-050333.json","markdown":"https://secwatch.observer/filing/0001628280-26-050333.md","text":"https://secwatch.observer/filing/0001628280-26-050333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000162828026050333/0001628280-26-050333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000162828026050333/avtr-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T10:15:04.869583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}